Streetbeat News

Assets

HUM

Over the past 10 years, Humana (NYSE:HUM) has outperformed the market by 8.26% on an annualized basis, producing an average annual return of 18.01%. If an investor had bought $100 of HUM stock 10 years ago, it would be worth $521.04 today. Currently, Humana has a market capitalization of $61.56 billion.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 5:30 pm

BKNG

Booking Holdings (NASDAQ:BKNG) has outperformed the market over the past 15 years, producing an average annual return of 30.31%. If an investor had bought $1000 of BKNG stock 15 years ago, it would be worth $50,558.83 today.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 5:30 pm

CPRT

Over the past 10 years, Copart (NASDAQ:CPRT) has outperformed the market by 16.78% on an annualized basis, producing an average annual return of 26.56%. If an investor had bought $1000 of CPRT stock 10 years ago, it would be worth $10,655.29 today.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 5:00 pm

TT

Trane Technologies (NYSE:TT) has outperformed the market over the past 5 years, producing an average annual return of 20.85%. If an investor had bought $1000 of TT stock 5 years ago, it would be worth $2,592.54 today.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 5:00 pm

BUSDUSD

PSFE

USDTUSD

Binance is looking to replace Paysafe as its banking partner. The crypto exchange has advised all Paysafe users to convert their EUR balances into Tether by Oct. 31. This comes after Paysafe cut ties with Binance, ending buying, selling, and trading support on the platform. Binance users will no longer be able to participate in EUR Spot trading and any open pending orders will be cancelled by the exchange. Binance had previously announced in June that Paysafe would end its support in September 2023.

Portfolio Pulse from Khyathi Dalal

September 28, 2023 | 4:59 pm

FTLF

FitLife Brands has announced that the U.S. Bankruptcy Court has approved its $18.5 million acquisition of substantially all of the assets of MusclePharm. This has led to a rise in FitLife Brands' shares.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:47 pm

STSS

Sharps Technology has signed an Asset Purchase Agreement to acquire the InjectEZ Facility and the associated $400 million 10-year purchase agreement with Nephron Pharmaceuticals. This news led to a decrease in Sharps Technology's share price.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 4:32 pm

EW

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years, producing an average annual return of 19.59%. If an investor had bought $100 of EW stock 15 years ago, it would be worth $1,450.63 today.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 4:30 pm

MPC

A significant bullish stance has been taken on Marathon Petroleum (NYSE:MPC) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 63% bullish and 36% bearish. The whales have been targeting a price range from $125.0 to $170.0 for Marathon Petroleum over the last 3 months. The price of MPC is up 1.73% at $155.06. Analysts from Mizuho, B of A Securities, Wells Fargo, and Raymond James have maintained their ratings on Marathon Petroleum.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 4:18 pm

COST

A significant investor has taken a bearish stance on Costco Wholesale (NASDAQ:COST), with 63% of recent trades being bearish. The price target for Costco Wholesale over the last 3 months has been between $560.0 to $600.0. The current price of COST is up 1.16% at $570.09. Analysts from Morgan Stanley, Deutsche Bank, BMO Capital, and Evercore ISI Group maintain positive ratings on Costco, while Telsey Advisory Group downgraded its action to Outperform with a price target of $575.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 4:03 pm